HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction

NCT03046914 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
600
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Seoul National University Hospital

Collaborators